Target intelligence / Profile preview

Gastrointestinal toxins and small molecules

Molecular classification
Other
01

Overview

Gastrointestinal toxins and small molecules represent a broad category of substances rather than a single biological receptor or enzyme. This group includes exogenous poisons, bacterial enterotoxins (such as those produced by Clostridioides difficile), and endogenous metabolic byproducts like uremic toxins (e.g., indoxyl sulfate) that accumulate in the gut. In a therapeutic context, these molecules are targeted by adsorbents, binders, or neutralizing antibodies to prevent their absorption into the bloodstream or to mitigate their local inflammatory effects on the intestinal mucosa. Because this term encompasses a wide variety of chemically diverse entities, it is generally classified as a target category or a group of pathological agents rather than a specific molecular target. Drugs interacting with this 'target' typically work through physical sequestration or direct biochemical neutralization to treat conditions ranging from acute poisoning and chronic kidney disease to infectious diarrhea.

Other names
EnterotoxinsIntestinal toxinsUremic toxins (gut-derived)Exogenous poisonsBacterial toxins
02

Mechanism of action

Adsorption of toxins to prevent systemic absorption; neutralization of bacterial toxins by monoclonal antibodies; sequestration of bile acids or phosphate in the gut lumen.

03

Biological functions

Other
04

Disease associations

InfectionInflammationChronic kidney diseasePoisoning
05

Safety considerations

Non-specific adsorption of co-administered medicationsConstipationElectrolyte imbalancesNutrient malabsorption
06

Interacting drugs

Activated charcoal

5 more in the full profile.

07

Biomarkers

Indoxyl sulfate levelsp-Cresyl sulfate levelsClostridioides difficile toxin A/B assay

Beyond the preview

Go deeper on Gastrointestinal toxins and small molecules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastrointestinal toxins and small molecules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call